Market cap
₹146 Cr
Revenue (TTM)
₹163 Cr
P/E Ratio
24.1
P/B Ratio
2.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹6 Cr
-
ROE
10.4 %
-
ROCE
13 %
-
Industry P/E
46.86
-
EV/EBITDA
10.6
-
Debt to Equity
0.4
-
Book Value
₹51.5
-
EPS
₹4.8
-
Face value
10
-
Shares outstanding
12,589,000
10 Years Aggregate
CFO
₹48.51 Cr
EBITDA
₹111.99 Cr
Net Profit
₹18.18 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lactose (India)
| 13.1 | 2.7 | 19.0 | 16.7 | 31.5 | 32.0 | 4.2 |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Lactose (India)
| -53.7 | 79.9 | 134.4 | 38.2 | 65.0 | 37.1 | -67.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lactose (India)
|
116.0 | 146.0 | 163.3 | 6.1 | 7.4 | 9.5 | 24.1 | 2.3 |
| 3,000.6 | 24,577.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69 | 14.9 | |
| 754.2 | 14,832.7 | 7,344.9 | 670.6 | 10.9 | 13.7 | 22 | 2.6 | |
| 428.8 | 16,406.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.5 | 4.2 | |
| 782.6 | 19,421.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.6 | 3.8 | |
| 991.8 | 15,788.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.6 | 2.2 | |
| 1,791.1 | 20,554.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 174.2 | 23,155.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 460.4 | 18,574.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.7 | 3.8 | |
| 1,771.0 | 28,787.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 135.2 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Lactose (India)
Lactose (India) Limited manufactures and trades in pharmaceutical products in India. The company offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in liquid dose forms. It also provides... disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic; and galacto-oligosaccharides, a prebiotic for use in dairy and bakery products, beverages, infant and clinical nutrition, and geriatric nutrition applications, as well as in products for children or adolescents. The company also exports its products to Russia, Kazakhstan, Belarus, Nigeria, Sri Lanka, and other countries. Lactose (India) Limited was founded in 1991 and is headquartered in Mumbai, India. Read more
-
Incorporated
1991
-
Chairman
--
-
Managing Director
Atul Maheshwari
-
Group
Toshniwal
-
Headquarters
Vadodara Dist, Gujarat
-
Website
Annual Reports
Announcements
View AnnouncementsResults - Financial Results For 31St March 2026
20-May-2026Clarification sought from Lactose India Ltd
24-Apr-2026No News & Announcements are available.
FAQs for Lactose (India)
What is the current share price of Lactose (India) Ltd Today?
The share price of Lactose (India) Ltd is ₹116.00 (BSE) as of 27-May-2026 IST. Lactose (India) Ltd has given a return of 31.52% in the last 3 years.
What is the current PB & PE ratio of Lactose (India) Ltd?
The P/E ratio of Lactose (India) Ltd is 24.09 times as on 27-May-2026, a 49 discount to its peers’ median range of 46.86 times.
The P/B ratio of Lactose (India) Ltd is 2.25 times as on 27-May-2026, a 41 discount to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.63
|
2.14
|
|
2024
|
25.87
|
3.73
|
|
2023
|
45.81
|
1.37
|
|
2022
|
30.79
|
1.92
|
|
2021
|
0.00
|
0.89
|
What is the 52 Week High and Low of Lactose (India) Ltd?
The 52-week high and low of Lactose (India) Ltd are Rs 136.70 and Rs 76.01 as of 28-May-2026.
What is the market cap of Lactose (India) Ltd?
Lactose (India) Ltd has a market capitalisation of ₹ 146 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Lactose (India) Ltd?
Before investing in Lactose (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.